Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much funding has been allocated by Government bodies and agencies to (a) site-specific brain tumour research, (b) site-specific breast cancer research, (c) site-specific prostate cancer research and (d) site-specific leukaemia research since 2002.
The Government funds research via many routes therefore there is not a single repository of funding. Government funders of health research do not allocate funding for specific disease areas. The level of research spend in a particular area is determined by factors including scientific potential and the number and scale of successful funding applications.
The Department’s National Institute for Health Research (NIHR) is a member of the National Cancer Research Institute (NCRI), which is a strategic partnership of United Kingdom cancer research funders. The following table shows total site-specific research spending by the NCRI’s Government partners for the period 2002/03 to 2019/20, the most recent data available.
Brain tumour | £24,848,028.73 |
Breast cancer | £148,744,495.51 |
Leukaemia | £130,655,832.13 |
Prostate cancer | £128,591,592.80 |